● Led CGP Product Solutions and defined a roadmap to maximize sales success.○ Managed oncology products portfolio (ImmunoID NeXT and NeXT Dx) and launched next-generationsequencing (NGS) based oncology products: (i) laboratory developed test (LDT) for patient management to HCPs (ii) Research Use Only (RUO) products for biomarker discovery to the Top 20 Pharma customers conducting clinical trials for translational research in IO (e.g. Merck), and (iii) led Clinical Trial Assay (CTA) development for registrational trials (e.g. Mapkure) to utilize as CDx.○ Played a pivotal role in managing biopharma oncology products, recognized as a key revenue driver for the company (>$60M annually).○ Strategized and defined product improvements: Collected voice of the customer (VOC) feedback from biopharma partners and providers, conducted in-depth market research to build product roadmap and business cases, reviewed scientific publications to stay informed about market trends and competitive landscape.○ Navigated complex regulatory landscapes including FDA (510k, PMA), IDE, CE-IVDR, CE-IVDD, LDT, NYS-DOH, ISO13485, HIPAA, GDPR, CAP, CLIA regulations.● Developed effective strategies for product improvements and led successful commercial launches.○ Awarded a spot bonus as merit recognition for driving cross-functional teams (e.g. marketing, regulatory, legal, sales, payor, medical affairs, R&D, external consultants and field application scientists) to manage multiple projects without direct reporting lines.○ Developed effective marketing strategies, go-to-market plans and marketing campaigns. Executed promotional tactics for HCPs and biopharma partners.○ Led the creation of crucial downstream marketing collaterals with differentiated messaging and followed MLR process. Developed creative concepts and core visual aids using data-driven approach that became highly utilized assets to drive awareness.○ Delivered impactful presentations to C-suite, board members and customers.

● Led NGS based cancer profiling tests and early cancer detection tests development and launch.○ Owned entire product portfolio that comprised of NGS-based (tumor tissue & ctDNA based liquid biopsy), PCR-based and circulating tumor cell (CTC)-based tests for healthcare providers and biopharma clients.○ Captured VOC, developed go-to-market strategies, key product positioning, differentiated messaging and finalized pricing models for products in various countries (USA, APAC, Europe).● Established new business growth in the India market and achieved a 10X increase in revenue.○ Managed the cross-functional team comprising of sales director, product manager, external genomic consultant and other vendors related to website development and branding messaging.○ Drove new business partnership opportunities globally and led product presentations to the management teams of various worldwide distributors. Delivered scientific presentations to HCPs globally.

Identified genes causing benign cartilage tumors in patients with Ollier disease and Maffucci syndrome.

Biochemical classification of plant cysteine proteases.